AN UNCONTROLLED OPEN PARALLEL STUDY OF USHNODAKPAN, VYAYAMA , AND BOTH IN MEDOVRIDDHI W.S.R TO B.M.I

Abstract

Introduction: Meda causes unctuousness in organs, enlargement of abdomen and flanks and also the disorders cough, dyspnoea etc. Medovriddhi is caused due to vitiation of body entities namely like Kapha Dosha, Meda Dhatu, Malaetc2. Acharya Charak has described Medovriddhi as excessive increase in quantity of Meda Dhatu leading to pendulous movements of flanks, abdomen and chest with morphological disproportion3. Increased Meda causes unctuousness in organs enlargement of abdomen, flanks. Acharya Vagabhatta has stated that the increased Medo Dhatu also produces the similar features of Mamsa Dhatu and also causes fatigue, dysponea on exertion, drooping of buttocks, breast and abdomen4. Ahar &Vihar plays an important role in Medovriddhi. Ushnodak is one of the Unique Dravadravyawhich is explained by Yogratnakara comes under Ahara used in Medovriddhi5. Practice of Vyayama brings about lightness, ability to work, stability, resistance to discomfort and alleviation of Doshas(specially Kapha), which comes under Vihara in CharakaSamhita6. Aim: • To study comparative effect of Ushnodakpana, Vyayamaandbothin Medovriddhi with special reference toB.M.I Objectives: 1. To evaluate the effect of Ushnodakpana in Medovriddhi. 2. To evaluate the effect of Vyayama inMedovriddhi. 3. To evaluate the effect of Ushnodakpana and Vyayama in Medovriddhi. 4. To compare the effect of Ushnodakpana, Vyayama, and both inMedovriddhi. Materials and Methods: 1. It is the comparative study in which 90 subjects were selected on the basis of inclusion and exclusion criteria. Group of 30 were randomlymade. 2. Medovriddhi were assessed BT, and AT with the ayurvedic criteria (Subjectively) and modern criteria B.M.I (Objectively) follow up in 15day. 3. Then they were divided in to three groups having 30 subjectseach. Ethical clearance Was obtained from Institutional Ethics Committee of Parul Institute of Ayurveda, Parul University. (IEC No PU/PIA/IECHR/2019/2), and Registered in Clinical Trial Registry India (CTRI/2019/03/018234). Results: • The final result showed that there is significant difference among three groups. Further we can observe that mean difference for Group C is greater than Group A and GroupB. • Hence, we conclude that effect observed in Group C is more than Group A and GroupB. Discussion: In this study Ushnodakpana, Vyayama and both plays a very effective role in the management of Medovriddhi. Here the Subjects with each passing day subjects feels lightness in body, taking interest in doing physical activities, decrease in heaviness. There is also a remarkable reduction of B.M.I seen in overweight persons. So, it is cleared that, there is an effective role of Ushnodakpan, Vyayama and both in Medovriddhi with in that also Ushnodakpan and Vyayama both coordinately plays a very good role in its management because of combineeffect. Conclusion: The observation showed that there is significant effect of Ushnodakpan (Group A), Vyayama (Group B) and both (Group C) in Medovriddhi within that also Ushnodakpan and Vyayama both together (Group C) shows more beneficial effect in Medovriddhi. The study shows that there is significant reduction of B.M.I in overweight persons within 30 days.